Characteristics of clinical Acinetobacter spp. strains

Folia Microbiologica

Volumn 47, Issue 5, 2002, Pages 579-582

  Hostacka A ^a   Klokocnikova L ^b  

^a INST OF PREV AND CLINICAL MEDICINE   (Slovakia)

^b Faculty of Natural Sciences   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

ACINETOBACTER; ACINETOBACTER BAUMANNII; ACINETOBACTER CALCOACETICUS; ACINETOBACTER HAEMOLYTICUS;

ANTIINFECTIVE AGENT; HISTAMINE; TRIACYLGLYCEROL LIPASE;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; BACTERIUM ADHERENCE; CLASSIFICATION; DRUG EFFECT; HUMAN; HYDROPHOBICITY; METABOLISM; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PHYSIOLOGY; SERUM BACTERICIDAL ACTIVITY;

ACINETOBACTER; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BACTERIAL ADHESION; BLOOD BACTERICIDAL ACTIVITY; DRUG RESISTANCE, BACTERIAL; HISTAMINE; HUMANS; HYDROPHOBICITY; LIPASE; MICROBIAL SENSITIVITY TESTS;

EID: 0036369172     PISSN: 00155632     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02818801     Document Type: Article

References (31)

1. AL-TAHHAN R.A., SANDRIN T.R., BODOUR A.A., MAIER R.M.: Rhamnolipid-induced removal of lipopolysaccharide from Pseudomonas aeruginosa: effect on cell surface properties and interaction with hydrophobic substrates. Appl.Environ.Microbiol. 66, 3262-3268 (2000).
2. AVRIL J.L., MESNARD R.: Factors influencing the virulence of Acinetobacter, pp. 77-82 in The Biology of Acinetobacter (K.J. Towner, E. Bergogne-Bérézin, C.A. Fewson, Eds). Plenum Publishing, New York 1991.
3. BELLO H., GONZALES G., DOMINGUEZ M., ZEMELMAN R., GARCIA A., MELLA S.: Activity of selected β-lactams, ciprofloxacin, and amikacin against different Acinetobacter baumannii biotypes from Chilean hospitals. Diagnos.Microbiol.Infect.Dis. 28, 183-186 (1997).
4. BENGE G. R.: Bactericidal activity of human serum against strains of Klebsiella from different sources. J.Med.Microbiol. 27, 11-15 (1988).
5. BERGOGNE-BÉRÉZIN E., TOWNER K.J.: Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin.Microbiol.Rev. 9, 148-165 (1996).
6. DA SILVA G.J., LEITÁO R., PEIXE L.: Emergence of carbapenem-hydrolyzing enzymes in Acinetobacter baumannii clinical isolates. J.Clin.Microbiol. 37, 2109-2110 (1999).
7. DE BEAUFORT A.J., BERNARDS A.T., DIJKSHOORN L., VAN BOVEN C.P.A.: Acinetobacter junii causes life-threatening sepsis in preterm infants. Acta Paediatr. 88, 772-775 (1999).
8. FORSTER D.H., DASCHNER F.D.: Acinetobacter species as nosocomial pathogens. Eur.J.Clin.Microbiol.Infect.Dis. 17, 73-77 (1998).
9. GALES A.C., JONES R.N., FORWARD K.R., LINARES J., SADER H.S., VERHOEF J.: Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY antimicrobial surveillance program (1997-1999). Clin.Infect.Dis. 32 (Suppl. 2), 104-113 (2001).
10. GATTRINGER R., NIKS M., OSTERTAG R., SCHWARZ K., MEDVEDOVIC H., GRANINGER W., GEORGOPOULOS A.: Evaluation of Midi-Tech automated colorimetric MIC reading for antimicrobial susceptibility testing. J.Antimicrob.Chemother. 49, 651-659 (2002).
11. GERNER-SMIDT P., FREDERIKSEN W.: Acinetobacter in Denmark - I. Taxonomy, antibiotic susceptibility, and pathogenicity of 112 clinical strains. APMIS 101, 815-825 (1993).
12. GUARDABASSI, L., PETERSEN A., OLSEN J.E., DALSGAARD A.: Antibiotic resistance in Acinetobacter spp. isolated from sewers receiving waste effluent from a hospital and a pharmaceutical plant. Appl.Environ.Microbiol. 50, 930-933 (1985).
13. HOŠTACKÁ A.: Alterations in surface hydrophobicity of Acinetobacter baumannii induced by meropenem. Folia Microbiol. 44, 267-270 (1999a).
14. HOŠTACKÁ A.: Vascular permeability factor and lipase produced by Acinetobacter baumannii treated with imipenem. Biomed.Lett. 60, 91-96 (1999b).
15. KÖLJALG S., VUOPIO-VARKILA J., LYYTIKÄINEN O., MIKELSAAR M., WADSTRÖM T.: Cell surface properties of Acinetobacter baumannii. APMIS 104, 659-666 (1996).
16. LONON M.K., WOODS D.E., STRAUS D.: Production of lipase by clinical isolates of Pseudomonas cepacia. J.Clin.Microbiol. 26, 979-984 (1988).
17. LÓPEZ-HERNÁNDEZ S., ALARCÓN T., LÓPÉZ-BREA M.: Biochemical characterization of chromosomal cephalosporinases from isolates belonging to the Acinetobacter baumannii complex. Clin.MicrobiolInfect.Dis. 7, 218-226 (2001).
18. MILER I., VONDRÁČEK J., HROMÁDKOVÁ L.: The bactericidal activity of sera of healthy neonates and of newborns with hyperbili-rubinaemia to Escherichia coli. Folia Microbiol. 24, 143-152 (1979).
19. NEMEC A., JANDA L., MELTER O., DIJKSHOORN L.: Genotypic and phenotypic similarity of multiresistant Acinetobacter baumannii iso'lates in the Czech Republic. J.Med.Microbiol. 48, 287-296 (1999).
20. OBANA Y.: Pathogenic significance of Acinetobacter calcoaceticus: analysis of experimental infection in mice. Microbiol. Immunol 30, 645-657 (1986).
21. PUZOVÁ H., SIEGFRIED L., KMEŤOVÁ M., ĎUROVIČOVÁ J., KERESTEŠOVÁ A.: Characteristics of Pseudomonas aeruginosa strains isolated from urinary tract infections. Folia Microbiol. 39, 337-341 (1994).
22. ROLLOF J., BRACONIER J.H., SÖDERSTRÖM C., NILSSON-EHLE P.: Interference of Staphylococcus aureus lipase with human granulocyte function. Eur.J.Clin.Microbiol.Infect.Dis. 7, 505-510 (1988).
23. ROSENBERG M., GUTNICK D., ROSENBERG E.: Adherence of bacteria to hydrocarbons: a simple method for measuring cell-surface hydrophobicity. FEMS Microbiol.Lett. 9, 29-33 (1980).
24. SEIFERT H., BAGINSKI R., SCHULZE A., PULVERER G.: Antimicrobial susceptibility of Acinetobacter species. Antimicrob.Agents Chemother. 37, 750-753 (1993).
25. TAKAHASHI A., YOMODA S., KOBAYASHI I., OKUBO T., TSUNODA M., IYOBE S.: Detection of carbapenemase-producing Acinetobacter baumannii in a hospital. J.Clin.Microbiol. 38, 526-529 (2000).
26. TIRUNARAYANAN M.O., LUNDBECK H.: Investigations on the enzymes and toxins of staphylococci. Acta Pathol.Microbiol.Scand. 72, 263-276 (1968).
27. TOLMASKY M.E., ACTIS L.A., CROSA J.H.: A histidine decarboxylase gene encoded by the Vibrio anguillarum plasmid pJM1 is essential for virulence: histamine is a precursor in the biosynthesis of anguibactin. Mol.Microbiol. 15, 87-95 (1995).
28. TRAUB W.H., GEIPEL U., SCHWARZE I., BAUER D.: A cluster of nosocomial cross-infection due to multiple antibiotic-resistant Acinetobacter baumannii. Characterization of the strain and antibiotic susceptibility studies. Chemotherapy 45, 349-359 (1999).
29. VILA J., RUIZ J., NAVIA M., BECERRIL B., GARCIA I., PEREA S., LÓPEZ-HERNÁNDEZ I., ALAMO I., BALLESTER F., PLANES A.M., BELTRAN J.M., JIMENEZ DE ANTA T.: Spread of amikacin resistance in Acinetobacter baumannii strains isolated in Spain due to an epidemic strain. J.Clin.Microbiol. 37, 758-761 (1999).
30. WISPLINGHOFF H., EDMOND M.B., PFALLER M.A., JONES R.N., WENZEL R.P., SEIFERT H.: Nosocomial bloodstream infections caused by Acinetobacter species in United States hospitals: clinical features, molecular epidemiology and antimicrobial susceptibility. Clin.Infect.Dis. 31, 690-697 (2000).
31. YOSHINAGA D.H., FRANK H.A.: Histamine-producing bacteria in decomposing skipjack tuna (Katsuwonus pelamis). Appl.Environ. Microbiol. 44, 447-452 (1982).